Pagaya may be one of the most misunderstood AI stocks: an AI-powered lending network still priced like a broken fintech. It trades at a single-digit P/E while turning profitable and scaling margins. It is high risk and high beta, with potentially asymmetric upside. x.com 

Pagaya may be one of the cheapest stocks relative to its growth, at about 12.5x earnings after earnings grew over 4x in 2025, with management guiding for roughly 50% more earnings growth in 2026. Revenue still grew 26% last year; the selloff reflects business-model risk in the current macro, and net income outpacing revenue reflects margin expansion rather than a topping business. FICO is safer but has far less upside. A significant position depends on a few factors still to be resolved. x.com  … Show more

Pagaya's strong quarter is rightly being ignored by the market, because Treasury yields are threatening to break out, which means more credit risk. @ThothCapital, in the post being answered, highlights a huge revenue beat, net income at the high end of guidance and raised guidance for revenue, adjusted EBITDA and net income. x.com 

Pagaya is one of the few already-profitable vertical AI applications, and industry-embedded software should gain value even as AI eats generic SaaS. It is fintech infrastructure, not a lender: AI credit decisions lift approvals for bank, auto and POS lending partners, while its ABS and forward-flow funding absorbs the loans. Its edge is data scale and deep credit-workflow embedding, not its static models. Risks include the credit cycle, ABS liquidity, regulation and partner concentration. x.com  … Show more

Pagaya looks mispriced at $12: the AI lending platform just closed a $600M AAA-rated ABS deal, so the bond market sees what the stock market doesn't. Citizens reiterated Outperform with a $22 price target. x.com 

Pagaya is still a credit business with a questionable moat, even if execution is good. There are too many world-class businesses out there to spend time convincing yourself an average one is exceptional; a proprietary model and a P/E of 4 do not make a wide moat. x.com  x.com 

Pagaya's 8.875% 2030 senior notes are the best self-help credit among the high-yield bonds reviewed, still priced far outside normal B risk at about 71.5 despite real liability improvements. Pagaya refinanced a costlier term loan, cutting about $40M a year of cash interest, and repriced its revolver. 2025 adjusted EBITDA rose 76% to $371M, with $410-460M guided for 2026, and ABS access held up. The bond needs genuine rerating, and Pagaya stays tied to consumer-credit and securitization risk. … Show more

Pagaya's operating leverage is kicking in, which supports a rerating if it keeps delivering. It posted a massive EPS beat and raised full-year guidance; priced at 7–9 times its expected $100–150 million net income this year, delivery should rerate the stock. The key metric is markdowns, up 25% year over year against 10% revenue growth and offset by cutting operating and other expenses $8 million. If markdowns keep jumping, it cannot grow revenue without loosening lending standards. x.com 

Pagaya is one of the cheapest stocks in the market, but its 15% short float shows the market still expects more downside than upside. Micron is the only name that currently makes financial sense. x.com 

Pagaya's CEO buying shares is a clear bullish signal. Per @trevhesinvests, CEO Gal Krubiner bought $540K of stock at $15.09, his first purchase since April 2024, and the last insider buy, in June 2025, came right before the stock ran from $18 to over $40. x.com